Literature DB >> 1173228

The use of intrathecal phenol for muscle spasms in multiple sclerosis. A description of two cases.

R A Browne, D V Catton.   

Abstract

Two cases of multiple sclerosis are described, in both of whom the disease started in yound adult life. This disability gradually progressed to the stage of paraplegia-in-flexion in which the lower limbs were fixed in adduction-and-flexion. Both patients developed painful muscle spasms which made life intolerable. These patients were treated by intrathecal phenol in glycerine in an effort to convert this spastic paralysis into a flaccid paralysis. The three advantages sought were: 1. To relieve the muscle spasms so that the patient could sit in a wheelchair and propel herself. 2. To relieve the pain of the spasms. 3. To allow access to the perineum for proper hygienic care of bladder and bowel function. The first patient obtained an excellent result (Figures 1, 2, 3) but blocks had to be repeated after approximately five months. The second patient after the block developed a good result in the right leg, but still had mild, but painless spasms in the muscles of the left leg (Figures 4 and 5). However, she was able to use a wheelchair and was discharged to a chronic hospital where she died of bulbar paralysis six months later. Intrathecal phenol thus appears to be a useful method for relieving muscle spasms and pain in the lower extremities in advanced cases of multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1173228     DOI: 10.1007/bf03004977

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  8 in total

1.  EXPERIENCES WITH THERAPEUTIC NERVE BLOCKS.

Authors:  H C BALL; D J PEARCE; J A DAVIES
Journal:  Anaesthesia       Date:  1964-04       Impact factor: 6.955

2.  Intrathecal phenol to relieve spasticity in paraplegia.

Authors:  P W NATHAN
Journal:  Lancet       Date:  1959-12-19       Impact factor: 79.321

3.  Intrathecal phenol in the treatment of reflex spasms and spasti city.

Authors:  R E KELLY; P C GAUTIER-SMITH
Journal:  Lancet       Date:  1959-12-19       Impact factor: 79.321

4.  Phenol block for control of hip flexor and adductor spasticity.

Authors:  E A Awad
Journal:  Arch Phys Med Rehabil       Date:  1972-12       Impact factor: 3.966

5.  Studies of spasticity in man. 3. Analysis of revlex activity evoked by noxious cutaneous stimulation.

Authors:  M R Dimitrijević; P W Nathan
Journal:  Brain       Date:  1968-06       Impact factor: 13.501

6.  Phenol motor point block in the management of muscular hypertonia.

Authors:  D Halpern; F E Meelhuysen
Journal:  Arch Phys Med Rehabil       Date:  1966-10       Impact factor: 3.966

7.  A physiologic approach to the evaluation and the management of spasticity with procaine and phenol nerve block: including a review of the physiology of the stretch reflex.

Authors:  A A Khalili; J G Benton
Journal:  Clin Orthop Relat Res       Date:  1966 Jul-Aug       Impact factor: 4.176

8.  Baclofen in the treatment of spasticity.

Authors:  P Hudgson; D Weightman
Journal:  Br Med J       Date:  1971-10-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.